Company Filing History:
11 out of 11 
1 out of 1 
1 out of 11 Years Active: 2004-2013
Title: Innovations by Anna Catania: Pioneering Therapeutic Applications
Introduction
Anna Catania is a prominent inventor based in Milan, Italy, renowned for her groundbreaking contributions in the field of medicinal chemistry. With an impressive portfolio of 13 patents, she has made significant strides in developing therapeutic solutions for various health conditions. Her innovative spirit drives her research towards enhancing the efficacy of treatments through novel compositions and methodologies.
Latest Patents
Among her latest patents, Anna Catania has made notable advancements with her work on melanocortin analogs with antimicrobial activity. This invention focuses on novel synthetic melanocortin peptides that demonstrate improved antimicrobial properties, opening new avenues in therapeutic applications. Additionally, she has developed a composition and method for treating urogenital conditions. This invention outlines a pharmaceutical composition that includes components such as KPV dimer and Carbopol®, among others, designed to effectively address urogenital health issues.
Career Highlights
Throughout her career, Anna has worked with esteemed companies such as Zengen, Inc. and Msh Pharma, Incorporated. Her work in these organizations has provided her with a platform to advance her research and patents, contributing significantly to the pharmaceutical industry.
Collaborations
Anna's journey has also been marked by fruitful collaborations with colleagues such as James M. Lipton and Ferruccio Bonino. Together, they have combined their expertise to push the boundaries of innovation in medicinal applications, fostering an environment of creativity and scientific advancement.
Conclusion
With her impactful inventions and collaborative spirit, Anna Catania continues to be a key player in the field of therapeutic development. Her patents highlight the intersection of creativity and scientific rigor, paving the way for new treatments that can significantly improve patient care and outcomes. As she forges ahead in her research, the medical community eagerly anticipates her next innovations.